Lysosomal Acid Lipase Deficiency: Genetics, Screening, and Preclinical Study.

Area of Science:

• Biochemistry
• Genetics
• Medical Science

Background:

• Lysosomal acid lipase (LAL) is crucial for breaking down cholesteryl esters via the endocytic pathway.
• LAL deficiency (LAL-D), caused by mutations in the LIPA gene, is a rare lysosomal storage disorder.
• LAL-D presents as severe Wolman disease or milder cholesteryl ester storage disease, affecting lipid metabolism and causing various symptoms.

Purpose of the Study:

• To review current knowledge on Lysosomal acid lipase deficiency (LAL-D).
• To cover the genetics, screening methods, and enzyme structure related to LAL-D.
• To discuss preclinical studies for novel LAL-D therapies.

Main Methods:

• Literature review of genetics, screening, and enzyme structure.
• Summary of current therapeutic approaches including enzyme replacement therapy.
• Analysis of preclinical data for future treatment development.

Main Results:

• LAL-D has distinct subtypes with varied clinical manifestations.
• Screening methodologies for LAL-D are established.
• Enzyme replacement therapy and novel therapeutic strategies are under investigation.

Conclusions:

• LAL-D is a rare but treatable lysosomal storage disorder.
• Understanding LAL enzyme structure and genetics is key to developing effective therapies.
• Ongoing research focuses on novel therapeutic interventions for LAL-D.